Events

MIP4Adapt Event | Preparing for Extreme Heat: Action Planning for Cities and Regions
MAY
Wed
20
10:00 - 11:30

Starts in 2 weeks from now

Location

Online

Programmes
Missions

This online event brings together regional and local authorities, policymakers, practitioners, and stakeholders to explore how Heat Action Planning can support cities in responding to extreme heat in an effective and fair way.

The session combines strategic insights, real-world experience and peer learning. 

What to expect:

  • A keynote on turning adaptation knowledge into practical resilience strategies
  • A city case study showcasing how Heat Action Planning works in practice
  • Peer exchanges on challenges, strategies and lessons learned
  • Facilitated interactive breakout sessions on:
    • Heat-health early warning systems, communication and outreach
    • Equity and fairness in Heat Action Planning
    • Coordination across sectors and stakeholders 

For more information and to register, please access MIP4Adapt Event.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.